At the news
? NEUTRALIMPACT 2/10 COURT-RULING filed Jun 15, 2026 at 20:00 ET
A Special Master in the District of Delaware denied GSK's motion to limit third-party inventor depositions to 10 combined hours across its patent infringement cases against Pfizer/BioNTech and Moderna. The ruling allows each defendant group up to 7 hours per inventor witness, preserving full examination rights for key inventors Dr. Geall and Dr. Mandl. This is a procedural discovery ruling with no financial exposure, no injunction, and no change to the underlying patent litigation merits.
- GSK's motion to limit defendants to 10 combined hours of third-party inventor depositions was DENIED
- Each defendant group (Pfizer/BioNTech and Moderna) retains the right to up to 7 hours per inventor witness under FRCP 30(d)(1)
- The ruling concerns two key witnesses: Dr. Andrew Geall (named inventor on all asserted patents) and Dr. Christian Mandl
- Fact discovery closes July 29, 2026, in all three related actions
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access